A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Public ClinicalTrials.gov record NCT04880876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Long-term Safety Study of Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Study identification
- NCT ID
- NCT04880876
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- 25mg Eluxadoline Drug
- 100mg Eluxadoline Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 12, 2021
- Primary completion
- Nov 30, 2032
- Completion
- Nov 30, 2032
- Last update posted
- Jul 16, 2025
2021 – 2032
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kindred Medical Institute, LLC /ID# 227595 | Corona | California | 92879 | — |
| Valencia Medical & Research Center /ID# 246221 | Miami | Florida | 33165 | — |
| Florida Research Center, Inc. /ID# 227597 | Miami | Florida | 33174 | — |
| Sleep Care Research Institute d/b/a Clinical Research Institute /ID# 227600 | Stockbridge | Georgia | 30281 | — |
| IPS Research Company /ID# 227594 | Oklahoma City | Oklahoma | 73106 | — |
| Preferred Primary Care Physicians, Inc. /ID# 227596 | Pittsburgh | Pennsylvania | 15236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04880876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04880876 live on ClinicalTrials.gov.